Search

everythinglearnresearchcommunity

for

Search:↓

Astaxanthin may reduce inflammation in women with PCOS, but doesn't significantly improve symptoms.

Adult women with acne in Iraq often have more severe symptoms and hormone-related issues than younger girls with acne.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Atorvastatin is less effective for women with Hashimoto's thyroiditis.

Low iron levels may be linked to hair loss in non-menopausal women.

Women with PCOS have a higher risk of heart disease.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Women with PCOS have altered brain structure and reduced cognitive performance.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Early hair loss in men and women may indicate a higher risk of heart disease and metabolic problems.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Two nutritional supplements improved hair growth and reduced hair loss in women with hair loss conditions.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Alopecia areata significantly harms women's self-image, causing reduced confidence and social isolation.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.